In a groundbreaking study published in Biochemical Genetics, researchers have unveiled a significant contributor to the complex mechanisms behind ovarian…
AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive…
Researchers at the forefront of immunological studies have recently unveiled a groundbreaking strategy aimed at improving tuberculosis (TB) vaccine formulations.…
The increasing reliance on aggregated electronic health record (EHR) datasets in medical research presents both unprecedented opportunities and significant challenges.…